Show Notes
When it comes to understanding the latest breakthroughs in medicine, many turn to the results of clinical trials. But have you ever stopped to ask whether your mental picture of those trials still holds up? With rapid advances in technology reshaping how research is conducted, a new model has emerged, one that’s redefining accessibility and participation. Enter decentralized clinical trials. Joining host Dr. Scott Sigman on this episode of Smart Medicine is Craig Lipset, a passionate innovator in the clinical research space. As the Co-founder of the Decentralized Trials & Research Alliance, former Head of Clinical Innovation at Pfizer, and long-time advocate for patient-centered research, Craig breaks down the what, why, and how behind the evolution of clinical trials. Together, they explore how the model is shifting and what that means for both patients and community doctors. From your digital twin and data ownership, to compensation for participation, Craig highlights the opportunities that come with doing research smarter. To wrap things up, Dr. Sigman hands Craig the reins, asking him to design his ideal system for medical research in the future.
More from Smart Medicine
Are you ready for the next wave of AI in healthcare?
What if the real promise of AI in medicine isn't to replace the human touch, but to give it back?
The role of the physician is changing, and the time to react is now.
Ask any surgeon what's wrong with the hospital system, and you'll get an earful. Ask what to do about it, and the room gets quiet. Well, except in this episode.
For ninety years, the name we gave one of the most common conditions in women's health pointed everyone in the wrong direction.